Probst Paul, Soleiman Afschin, Zbornay Viliam, Benesch Thomas, Haas Martin
Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University Vienna, Vienna, Austria.
Transplantation. 2008 Feb 15;85(3):391-7. doi: 10.1097/TP.0b013e3181622f7d.
The presence of vacuolar (v)H+-ATPase in distal tubule alpha-intercalated cells is essential for hydrogen excretion and maintenance of acid-base homeostasis. Loss of vH+-ATPase after kidney transplantation could cause posttransplant distal renal tubular acidosis (dRTA).
Immunostaining of the kidney specific vH+-ATPase of cortical collecting duct cells (CCT) was performed in 37 kidney biopsies taken immediately prior to transplantation and after engraftment (median [range]: 10 [1-181] months). Apical or intracytoplasmatic staining intensity was classified as grade 0 (absent), grade 1 (weak), or grade 2 (strong), and positive cells expressed as percentage of all CCT cells. In addition, kidney biopsies were scored for damage by the Banff schema. Serum and urinary pH, anion gap, and serum potassium were obtained for the diagnoses of dRTA.
Fourteen transplant recipients had dRTA type I, 5 had rate-limited RTA, six had type IV dRTA, and 12 had no RTA. In pretransplant biopsies, 40% [3-77%] of CCT cells were positive for vH+-ATPase but only 17% [0-39%] after transplantation (P<0.0001). The loss of vH+-ATPase expression was similar in patients with dRTA type I (-21%), type IV (-25%), rate limited RTA (-21%), or no RTA (-29%). The decrease affected predominantly the apical proton pump expression. The individual loss of vH+-ATPase expression was not related to the time elapsed since transplantation, immunosuppressive drugs, acute transplant rejection, or tubulointerstitial changes.
Kidney transplantation leads to a general decrease of distal tubular vH+-ATPase expression. Loss of proton pump activity occurs unrelated to immunosuppressive therapy or transplant related histologic changes.
远端小管α-闰细胞中液泡型(v)H⁺-ATP酶的存在对于氢排泄和酸碱平衡的维持至关重要。肾移植后vH⁺-ATP酶的缺失可导致移植后远端肾小管酸中毒(dRTA)。
对37例肾活检组织进行肾皮质集合管细胞(CCT)特异性vH⁺-ATP酶的免疫染色,这些活检组织取自移植前及移植后(中位时间[范围]:10 [1 - 181]个月)。将顶端或胞质内染色强度分为0级(无)、1级(弱)或2级(强),阳性细胞以占所有CCT细胞的百分比表示。此外,根据Banff标准对肾活检组织的损伤进行评分。获取血清和尿液pH值、阴离子间隙及血清钾以诊断dRTA。
14例移植受者为I型dRTA,5例为速率限制型RTA,6例为IV型dRTA,12例无RTA。移植前活检中,40% [3 - 77%]的CCT细胞vH⁺-ATP酶呈阳性,但移植后仅为17% [0 - 39%](P<0.0001)。I型dRTA(-21%)、IV型(-25%)、速率限制型RTA(-21%)或无RTA(-29%)患者中vH⁺-ATP酶表达的丧失相似。这种减少主要影响顶端质子泵的表达。vH⁺-ATP酶表达的个体丧失与移植后的时间、免疫抑制药物、急性移植排斥或肾小管间质变化无关。
肾移植导致远端小管vH⁺-ATP酶表达普遍下降。质子泵活性的丧失与免疫抑制治疗或移植相关的组织学变化无关。